Evidence map›Paper›PMID 29318209›Full record

ReviewKidney international reports2017

Depression in Chronic Kidney Disease and End-Stage Renal Disease: Similarities and Differences in Diagnosis, Epidemiology, and Management.

Shayan Shirazian, Candace D Grant, Olufemi Aina, Joseph Mattana, Farah Khorassani, Ana C Ricardo

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Kidney international reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 8 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 8 syntheses or guidelines pooled it, 308 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shayan ShirazianDivision of Nephrology, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA.
Candace D GrantDivision of Nephrology, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA.
Olufemi AinaDivision of Nephrology, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA.
Joseph MattanaDivision of Nephrology, Department of Medicine, Winthrop University Hospital, Mineola, New York, USA.
Farah KhorassaniDepartment of Clinical Health Professions, St. John's University College of Pharmacy and Health Sciences, Queens, New York, USA.
Ana C RicardoDivision of Nephrology, Department of Medicine, University of Illinois, Chicago, Illinois, USA.
Winthrop-University Hospital · USSt. John's University · USUniversity of Illinois Chicago · US

Funding

Gender Disparities and Vascular Function in Chronic Kidney Disease OutcomesK23DK094829 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RICARDO, ANA CATHERINE · 2013 to 2017
$800k
NIDDK NIH HHS K23 DK094829
6 · The paper itself

Abstract

Depression is highly prevalent and is associated with poor quality of life and increased mortality among adults with chronic kidney disease (CKD), including those with end-stage renal disease (ESRD). However, there are several important differences in the diagnosis, epidemiology, and management of depression between patients with non-dialysis-dependent CKD and ESRD. Understanding these differences may lead to a better understanding of depression in these 2 distinct populations. First, diagnosing depression using self-reported questionnaires may be less accurate in patients with ESRD compared with CKD. Second, although the prevalence of interview-based depression is approximately 20% in both groups, the risk factors for depression may vary. Third, potential mechanisms of depression might also differ in CKD versus ESRD. Finally, considerations regarding the type and dose of antidepressant medications vary between CKD and ESRD. Future studies should further examine the mechanisms of depression in both groups, and test interventions to prevent and treat depression in these populations.

Indexed as

depressiondiagnosisepidemiologykidney diseaseoutcomestreatment

Identifiers

PMID29318209
PMCPMC5720531
OpenAlexW2523381241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.